Skip to main content
OpenTrials

Clinical trial condition

Exocrine Pancreatic Insufficiency

Explore clinical trials studying Exocrine Pancreatic Insufficiency. Study availability and eligibility vary by location and protocol.

104 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Exocrine Pancreatic Insufficiency trial results

Completed

A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

NCT00414908

Conditions
Chronic Disease, Chronic Pancreatitis, Digestive System Diseases, +9 more
Locations
  • Site 9 Scottsdale, Arizona, United States
  • Site 22 Bristol, Connecticut, United States
  • Site 7 Tampa, Florida, United States
  • Site 6 Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Completed

A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency

NCT00401076

Conditions
Chronic Disease, Digestive System Diseases, Disease Attributes, +7 more
Locations
  • Site Reference ID/Investigator# 45211 Fukuoka, Japan
  • Site Reference ID/Investigator# 45297 Fukuoka, Japan
  • Site Reference ID/Investigator# 45220 Hiroshima, Japan
  • Site Reference ID/Investigator# 45279 Hiroshima, Japan
View all 17 locations
View Trial Details
Completed

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT00775528

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +7 more
Locations
  • Site 11 Boise, Idaho, United States
  • Site 5 Louisville, Kentucky, United States
  • Site 9 Boston, Massachusetts, United States
  • Site 6 Ann Arbor, Michigan, United States
View Trial Details
Completed

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT00510484

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Site 11 Long Beach, California, United States
  • Site 10 Los Angeles, California, United States
  • Site 13 San Francisco, California, United States
  • Site 5 Miami, Florida, United States
View all 23 locations
View Trial Details
Completed

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

NCT00690820

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +7 more
Locations
  • Site 2 Iowa City, Iowa, United States
  • Site 5 Louisville, Kentucky, United States
  • Site 9 Boston, Massachusetts, United States
  • Site 6 Ann Arbor, Michigan, United States
View Trial Details

Related conditions